XML 34 R19.htm IDEA: XBRL DOCUMENT
v3.25.2

EQUITY INVESTMENTS | 12 Months Ended
--- | ---
Jun. 30, 2025
Investments, Debt and Equity Securities [Abstract] |
EQUITY INVESTMENTS | EQUITY INVESTMENTS The Company's equity investments, classified as Equity investments on the Consolidated Balance Sheets, as of June 30, 2025 are represented by the following:
| June 30, 2025 |  | June 30, 2024
Equity method investments: |  |  |
KKW Holdings (a) | $ | — |  |  | $ | 5.6 |
Equity investments at fair value: |  |  |
Wella (b) | 1,002.0 |  |  | 1,085.0 |
Total equity investments | $ | 1,002.0 |  |  | $ | 1,090.6 |
(a)On January 4, 2021, the Company completed its purchase of 20% of the outstanding equity of KKW Holdings, LLC (“KKW Holdings”). The Company accounted for this minority investment under the equity method, given it had the ability to exercise significant influence over, but not control, the investee. The carrying value of the Company’s investment included basis differences allocated to amortizable intangible assets. On March 31, 2025, the Company sold and derecognized its investment in KKW Holdings. During the years ended 2025, 2024 and 2023, the Company recognized $2.6, $3.3, and $3.7, respectively, representing its share of the investee’s net loss and the amortization of basis differences in Other expense (income), net within the Consolidated Statements of Operations. (b)As of June 30, 2025 and 2024, the Company's stake in Wella was 25.84% and 25.84%, respectively. On March 31, 2025, the Company sold its 20% equity investment in KKW Holdings pursuant to an agreement entered into between the Company, KKW Holdings, and New KKW Holdings, LLC (the “KKW Sale Agreement”). This agreement terminated the collaboration agreement, which gave the Company the right and license to manufacture, advertise, promote, distribute, and sell certain Kim Kardashian beauty products and use certain intellectual property owned or licensed to KKW Holdings (the “KKW Collaboration Agreement”). The total consideration received in this transaction was $74.0. As a result of this transaction, the Company derecognized the remaining book value of the KKW Collaboration Agreement and related assets (See Footnote 9— Goodwill and Other Intangibles, net), and its investment in KKW Holdings. The Company recognized a loss of $71.0 related to the termination of KKW Collaboration Agreement and a loss of $1.5 on the sale of its investment in KKW Holdings, including in Selling, General, Administrative expenses and Other expense, net, respectively in the Consolidated Statement of Operations. The following table presents summarized financial information of the Company’s equity method investees for the years ended June 30, 2025 and 2024. Amounts presented represent combined totals at the investee level and not the Company’s proportionate share:
Summarized Statements of Operations information: | Year Ended June 30, 2025 |  | Year Ended June 30, 2024
Net revenues | $ | 2,692.9 |  |  | $ | 2,590.1 |
Gross profit | 1,842.3 |  |  | 1,732.8 |
Operating income | 230.9 |  |  | 42.7 |
Income (loss) before income taxes | 33.4 |  |  | (176.4) |
Net loss | (15.0) |  |  | (133.8) |
Summarized Balance Sheets information: | June 30, 2025 |  | June 30, 2024
Current assets | $ | 1,133.8 |  |  | $ | 1,080.4 |
Noncurrent assets | 4,177.9 |  |  | 4,322.3 |
Total assets | 5,311.7 |  |  | 5,402.7 |
Current liabilities | 991.6 |  |  | 967.3 |
Noncurrent liabilities | 2,762.9 |  |  | 2,687.6 |
Total liabilities | 3,754.5 |  |  | 3,654.9 |
As of June 30, 2025, the Wella Company had 30.0 million shares of issued common stock, of which Coty held 25.84%. The Wella Company had total equity inclusive of redeemable preferred stock of $1,557.2 as of June 30, 2025. The following table summarizes movements in equity investments with fair value option that are classified within Level 3 for the period ended June 30, 2025. There were no internal movements to or from Level 3 from Level 1 or Level 2 for the period ended June 30, 2025.
Equity investments at fair value: |
Balance as of June 30, 2024 | $ | 1,085.0 |
Total losses included in earnings | (83.0) |
Balance as of June 30, 2025 | $ | 1,002.0 |
Level 3 significant unobservable inputs sensitivity The following table summarizes the significant unobservable inputs used in Level 3 valuation of the Company’s investments carried at fair value as of June 30, 2025. Included in the table are the inputs or range of possible inputs that have an effect on the overall valuation of the financial instruments.
| Fair value |  | Valuation Technique |  | Unobservable input |  | Range
Equity investments at fair value | $ | 1,002.0 |  |  | Discounted cash flows |  | Discount rate |  | 9.25% (a)
|  | Growth rate |  | 1.8% – 6.0% (a)
| Market multiple |  | Revenue multiple |  | 2.0x – 2.1x (b)
|  | EBITDA multiple |  | 9.3x – 10.2x (b)
(a)The primary unobservable inputs used in the fair value measurement of the Company’s equity investments with fair value option, when using a discounted cash flow method, are the discount rate and revenue growth rate. Significant increases (decreases) in the discount rate in isolation would result in a significantly lower (higher) fair value measurement. The Company estimates the discount rate based on the investees' projected cost of equity and debt. The revenue growth rate is forecasted for future years by the investee based on their best estimates. Significant increases (decreases) in the revenue growth rate in isolation would result in a significantly higher (lower) fair value measurement. (b)The primary unobservable inputs used in the fair value measurement of the Company’s equity investments with fair value option, when using a market multiple method, are the revenue multiple and EBITDA multiple. Significant increases (decreases) in the revenue multiple or EBITDA multiple in isolation would result in a significantly higher (lower) fair value measurement. The market multiples are derived from a group of guideline public companies.

X
- References No definition available. + Details
Name: | us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for investments in certain debt and equity securities. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 940 -SubTopic 320 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/940-320/tableOfContent Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name Regulation S-K (SK) -Number 229 -Section 1403 -Paragraph b -Publisher SEC Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 320 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/320/tableOfContent Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 320 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 10 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481800/320-10-50-10 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6B -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6B Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6B -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6B Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 320 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/942-320/tableOfContent + Details
Name: | us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration